J. Stern & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Sell
52,801
-2,048
-4% -$983K 2.5% 19
2026
Q1
$27M Buy
54,849
+471
+0.9% +$256K 2.61% 18
2025
Q4
$31.5M Buy
54,378
+151
+0.3% +$85.4K 2.69% 18
2025
Q3
$26.3M Sell
54,227
-8,926
-14% -$4.15M 1.99% 17
2025
Q2
$25.1M Buy
63,153
+1,600
+3% +$669K 2.14% 19
2025
Q1
$30.6M Buy
61,553
+4,015
+7% +$2.17M 2.94% 18
2024
Q4
$29.9M Buy
57,538
+3,198
+6% +$1.76M 2.82% 19
2024
Q3
$33.6M Buy
54,340
+1,415
+3% +$838K 3.58% 16
2024
Q2
$29.3M Buy
52,925
+739
+1% +$423K 3.48% 17
2024
Q1
$30.3M Buy
52,186
+12,267
+31% +$6.88M 3.84% 16
2023
Q4
$21.5M Buy
+39,919
New +$19.3M 3.92% 13

Other funds holding TMO

J. Stern & Co's TMO Position: Q2 2026 in Review

J. Stern & Co reduced its Thermo Fisher Scientific (TMO) stake by 3.7% in Q2 2026, selling an estimated $983K and leaving 52,801 shares worth $26.5M. The position accounts for 2.5% of the portfolio, ranked #19.

J. Stern & Co first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $33.6M in Q3 2024. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • J. Stern & Co held 52,801 shares of Thermo Fisher Scientific worth $26.5M as of Q2 2026.
  • J. Stern & Co sold 2,048 Thermo Fisher Scientific shares in Q2 2026, an estimated $983K.
  • Thermo Fisher Scientific made up 2.5% of J. Stern & Co's portfolio in Q2 2026, its #19 holding.
  • J. Stern & Co first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • J. Stern & Co's Thermo Fisher Scientific position peaked at $33.6M in Q3 2024.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on J. Stern & Co's 13F filing for Q2 2026, filed 14 Aug 2026.